Literature DB >> 9084148

Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.

M Rupnik1, V Braun, F Soehn, M Janc, M Hofstetter, R Laufenberg-Feldmann, C von Eichel-Streiber.   

Abstract

We have used six independent polymerase chain reactions (A1-A3 and B1-B3) for amplification of the entire sequence of the two toxin genes tcdA and tcdB of several Clostridium difficile strains. With this approach we have detected (1) restriction site polymorphisms which are distributed all over the genes, and (2) deletions that could be found only in tcdA. Characteristic differences between strains were mainly focused to the 5' third of tcdB (B1 fragment) and/or the 3' third of tcdA (A3 fragment). The possible use of our approach for typing of C. difficile toxin genes is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9084148     DOI: 10.1111/j.1574-6968.1997.tb10288.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  31 in total

1.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.

Authors:  Jason G S Ho; Antonio Greco; Maja Rupnik; Kenneth K-S Ng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 3.  An Update on Clostridium difficile Toxinotyping.

Authors:  Maja Rupnik; Sandra Janezic
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

4.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.

Authors:  M J Alfa; A Kabani; D Lyerly; S Moncrief; L M Neville; A Al-Barrak; G K Harding; B Dyck; K Olekson; J M Embil
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 6.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

7.  Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.

Authors:  Wing Huen A Chow; Cindy McCloskey; Yanhong Tong; Lin Hu; Qimin You; Ciarán P Kelly; Huimin Kong; Yi-Wei Tang; Wen Tang
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

8.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Authors:  Ruth Murray; Dave Boyd; Paul N Levett; Michael R Mulvey; Michelle J Alfa
Journal:  BMC Infect Dis       Date:  2009-06-28       Impact factor: 3.090

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.